A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier
Source abstract
Abstract
This study was aimed at preparing and characterising kojic acid nanostructured lipid carriers (KA-NLCs) for delivery to skin. KA-NLCs were prepared using high-speed homogenization followed by ultra-probe sonication method. KA-NLCs were optimized by glyceryl mono-stearate (GMS) and cholesterol (Chol) as solid lipid excipients, oleic acid (OA) as liquid lipid excipient, span 60 (SP 60) and Tween 20 (Tw 20) as co-emulsifiers. For optimized formulation (KA-NLC3), values of particle size, encapsulation efficiency, drug loading, polydispersity index (PDI) and zeta potential (ZP) were found to be 172.9 ± 7.1 nm, 76.4 ± 0.1%, 17.6 ± 1.3%, 0.3 ± 0.1 and -39.1 ± 2.7 mV, respectively. KA-NLC3 was stable at 4 °C and 25 for 3 months. TEM image confirmed these results. ATR-FTIR, DSC and PXRD results indicated suitable entrapment of KA in NLCs without any chemical interaction. The release profile of KA-NLC3 followed a sustained pattern. KA-NLC3 has potent tyrosinase inhibitory activity in comparison with pure KA. Nanoparticles showed a higher antioxidant activity than pure KA. The results of the ex vivo and in vitro percutaneous absorption showed that KA-NLC3 improved percutaneous delivery of KA. Concentrations below 250 μg/mL were determined as suitable concentrations for KA-NLC3. It seems to be biocompatible formulation for the cosmetics aims.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Acne and Rosacea Treatments and Effects · melanin and skin pigmentation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran
Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Gastrointestinal Cancer Research Center, Non-communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran
Funding
Mazandaran University of Medical Sciences
References (11)
Show source-provided references
1. 10.1080/09168451.2018.145917610.1080/09168451.2018.1459176 ↗
2. 10.1016/j.clindermatol.2013.05.02610.1016/j.clindermatol.2013.05.026 ↗
3. 10.1016/j.biopha.2018.12.00610.1016/j.biopha.2018.12.006 ↗
4. 10.1080/21691401.2020.177027110.1080/21691401.2020.1770271 ↗
5. 10.1016/j.ijpharm.2008.10.00310.1016/j.ijpharm.2008.10.003 ↗
6. 10.1007/s11947-012-0845-210.1007/s11947-012-0845-2 ↗
7. 10.1016/j.colcom.2017.11.00610.1016/j.colcom.2017.11.006 ↗
8. 10.1016/j.jddst.2019.02.01710.1016/j.jddst.2019.02.017 ↗
9. 10.1016/j.ijpharm.2017.04.02010.1016/j.ijpharm.2017.04.020 ↗
10. 10.3109/21691401.2013.83268310.3109/21691401.2013.832683 ↗
11. 10.1080/10837450.2019.159613310.1080/10837450.2019.1596133 ↗